These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11782055)

  • 1. Item response models for joint analysis of quality of life and survival.
    Wang C; Douglas J; Anderson S
    Stat Med; 2002 Jan; 21(1):129-42. PubMed ID: 11782055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Item response models for longitudinal quality of life data in clinical trials.
    Douglas JA
    Stat Med; 1999 Nov; 18(21):2917-31. PubMed ID: 10523750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebo effect-adjusted assessment of quality of life in placebo-controlled clinical trials.
    Eickhoff JC
    Stat Med; 2008 Apr; 27(9):1387-402. PubMed ID: 18219702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simulation program for estimating statistical power of Cox's proportional hazards model assuming no specific distribution for the survival time.
    Akazawa K; Nakamura T; Moriguchi S; Shimada M; Nose Y
    Comput Methods Programs Biomed; 1991 Jul; 35(3):203-12. PubMed ID: 1935013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group.
    Feldman AM; Bristow MR; Parmley WW; Carson PE; Pepine CJ; Gilbert EM; Strobeck JE; Hendrix GH; Powers ER; Bain RP
    N Engl J Med; 1993 Jul; 329(3):149-55. PubMed ID: 8515787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneously modelling censored survival data and repeatedly measured covariates: a Gibbs sampling approach.
    Faucett CL; Thomas DC
    Stat Med; 1996 Aug; 15(15):1663-85. PubMed ID: 8858789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multilevel modelling of clustered grouped survival data using Cox regression model: an application to ART dental restorations.
    Wong MC; Lam KF; Lo EC
    Stat Med; 2006 Feb; 25(3):447-57. PubMed ID: 16143989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators.
    Cohn JN; Goldstein SO; Greenberg BH; Lorell BH; Bourge RC; Jaski BE; Gottlieb SO; McGrew F; DeMets DL; White BG
    N Engl J Med; 1998 Dec; 339(25):1810-6. PubMed ID: 9854116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Joint modeling of multivariate longitudinal measurements and survival data with applications to Parkinson's disease.
    He B; Luo S
    Stat Methods Med Res; 2016 Aug; 25(4):1346-58. PubMed ID: 23592717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential monitoring of survival data with the Wilcoxon statistic.
    Lan KK; Rosenberger WF; Lachin JM
    Biometrics; 1995 Sep; 51(3):1175-83. PubMed ID: 7548701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic heart failure and the quality of life.
    Alhaddad IA
    N Engl J Med; 1999 May; 340(19):1511-2. PubMed ID: 10328721
    [No Abstract]   [Full Text] [Related]  

  • 12. A multistate Markov chain model for longitudinal, categorical quality-of-life data subject to non-ignorable missingness.
    Cole BF; Bonetti M; Zaslavsky AM; Gelber RD
    Stat Med; 2005 Aug; 24(15):2317-34. PubMed ID: 15977292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Item-level assessment of the irritable bowel syndrome quality of life questionnaire in patients with diarrheal irritable bowel syndrome.
    Andrae DA; Covington PS; Patrick DL
    Clin Ther; 2014 May; 36(5):663-79. PubMed ID: 24813429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visualization and dynamics of multidimensional health-related quality-of-life-adjusted overall survival: a new analytic approach.
    Andrei AC; Grady KL
    Qual Life Res; 2014 Jun; 23(5):1411-9. PubMed ID: 24395525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysing multicentre competing risks data with a mixed proportional hazards model for the subdistribution.
    Katsahian S; Resche-Rigon M; Chevret S; Porcher R
    Stat Med; 2006 Dec; 25(24):4267-78. PubMed ID: 16960919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic heart failure and the quality of life.
    Pritzker MR
    N Engl J Med; 1999 May; 340(19):1511; author reply 1512. PubMed ID: 10328720
    [No Abstract]   [Full Text] [Related]  

  • 17. A Markov chain Monte Carlo EM algorithm for analyzing interval-censored data under the Cox proportional hazards model.
    Goggins WB; Finkelstein DM; Schoenfeld DA; Zaslavsky AM
    Biometrics; 1998 Dec; 54(4):1498-507. PubMed ID: 9883548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of a dose-dependent increase in mortality with vesnarinone among patients with severe heart failure.
    LeJemtel TH
    Curr Cardiol Rep; 1999 May; 1(1):31. PubMed ID: 10980817
    [No Abstract]   [Full Text] [Related]  

  • 19. Some adaptive monte carlo methods for Bayesian inference.
    Tierney L; Mira A
    Stat Med; 1999 Sep 15-30; 18(17-18):2507-15. PubMed ID: 10474156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inferences for joint modelling of repeated ordinal scores and time to event data.
    Chakraborty A; Das K
    Comput Math Methods Med; 2010 Sep; 11(3):281-95. PubMed ID: 20721765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.